Information Provided By: 
Fly News Breaks for July 24, 2015
REGN
Jul 24, 2015 | 08:45 EDT
Bernstein notes that today is the PDUFA day for Regeneron's (REGN) and Amgen's (AMGN) Praluent, which would be the first antibody approved for cholesterol treatment in the U.S. The firm expects the drug to be approved today. After surveying doctors on the drug, Bernstein finds that their attitudes towards it are "remarkably positive." The firm keeps an Outperform rating on Regeneron and a Market Perform rating on Amgen.
News For REGN From the Last 2 Days
There are no results for your query REGN
